231 related articles for article (PubMed ID: 33627711)
41. Integrated analysis reveals five potential ceRNA biomarkers in human lung adenocarcinoma.
Liu Y; Xie D; He Z; Zheng L
PeerJ; 2019; 7():e6694. PubMed ID: 31106044
[TBL] [Abstract][Full Text] [Related]
42. The relationship between LncRNAs and lung adenocarcinoma as well as their ceRNA network.
Zhao Y; Ma S; Cui Z; Li S; Chen Y; Yin Y; Yin Z
Cancer Biomark; 2021; 31(2):165-176. PubMed ID: 33896828
[TBL] [Abstract][Full Text] [Related]
43. Identification of novel mRNA-miRNA-lncRNA competing endogenous RNA network associated with prognosis of breast cancer.
Zhong G; Lou W; Yao M; Du C; Wei H; Fu P
Epigenomics; 2019 Oct; 11(13):1501-1518. PubMed ID: 31502865
[No Abstract] [Full Text] [Related]
44. A novel lncRNA-miRNA-mRNA competitive endogenous RNA network for uveal melanoma prognosis constructed by weighted gene co-expression network analysis.
Yu H; Cheng Y; Li W; Li Z; Wu P; Qiu S; Zeng B; Huang B
Life Sci; 2020 Nov; 260():118409. PubMed ID: 32926921
[TBL] [Abstract][Full Text] [Related]
45. Identification of potential prognostic long non‑coding RNA signatures based on a competing endogenous RNA network in lung adenocarcinoma.
Wang X; Ding Y; Da B; Fei Y; Feng G
Oncol Rep; 2018 Dec; 40(6):3199-3212. PubMed ID: 30272355
[TBL] [Abstract][Full Text] [Related]
46. SNHG6 functions as a competing endogenous RNA to regulate E2F7 expression by sponging miR-26a-5p in lung adenocarcinoma.
Liang R; Xiao G; Wang M; Li X; Li Y; Hui Z; Sun X; Qin S; Zhang B; Du N; Liu D; Ren H
Biomed Pharmacother; 2018 Nov; 107():1434-1446. PubMed ID: 30257360
[TBL] [Abstract][Full Text] [Related]
47. Comprehensive Analysis and Validation of Competing Endogenous RNA Network and Tumor-infiltrating Immune Cells in Lung Adenocarcinoma.
Liu Y; Wu Q; Li J; Jia W; Zhai X; Yu J; Zhu H
Comb Chem High Throughput Screen; 2022; 25(13):2240-2254. PubMed ID: 35331104
[TBL] [Abstract][Full Text] [Related]
48. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
[TBL] [Abstract][Full Text] [Related]
49. Integrative Analysis of ceRNA Network Reveals Functional lncRNAs in Intrahepatic Cholangiocarcinoma.
Zhou D; Gao B; Yang Q; Kong Y; Wang W
Biomed Res Int; 2019; 2019():2601271. PubMed ID: 31886187
[TBL] [Abstract][Full Text] [Related]
50. Construction of an mRNA-miRNA-lncRNA network prognostic for triple-negative breast cancer.
Huang Y; Wang X; Zheng Y; Chen W; Zheng Y; Li G; Lou W; Wang X
Aging (Albany NY); 2021 Jan; 13(1):1153-1175. PubMed ID: 33428596
[TBL] [Abstract][Full Text] [Related]
51. Prognostic value of CASC15 and LINC01600 as competitive endogenous RNAs in lung adenocarcinoma: An observational study.
Zhou F
Medicine (Baltimore); 2023 Nov; 102(45):e36026. PubMed ID: 37960753
[TBL] [Abstract][Full Text] [Related]
52. The LncRNA NEAT1 Accelerates Lung Adenocarcinoma Deterioration and Binds to Mir-193a-3p as a Competitive Endogenous RNA.
Xiong DD; Li ZY; Liang L; He RQ; Ma FC; Luo DZ; Hu XH; Chen G
Cell Physiol Biochem; 2018; 48(3):905-918. PubMed ID: 30036873
[TBL] [Abstract][Full Text] [Related]
53. Comprehensive analysis of differentially expressed profiles and reconstruction of a competing endogenous RNA network in papillary renal cell carcinoma.
Luo Q; Cui M; Deng Q; Liu J
Mol Med Rep; 2019 Jun; 19(6):4685-4696. PubMed ID: 30957192
[TBL] [Abstract][Full Text] [Related]
54. LncRNA MAFG-AS1 boosts the proliferation of lung adenocarcinoma cells via regulating miR-744-5p/MAFG axis.
Sui Y; Lin G; Zheng Y; Huang W
Eur J Pharmacol; 2019 Sep; 859():172465. PubMed ID: 31211984
[TBL] [Abstract][Full Text] [Related]
55. KRT8 and KRT19, associated with EMT, are hypomethylated and overexpressed in lung adenocarcinoma and link to unfavorable prognosis.
Wang W; He J; Lu H; Kong Q; Lin S
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32519739
[TBL] [Abstract][Full Text] [Related]
56. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
[No Abstract] [Full Text] [Related]
57. Molecular characterization of lung adenocarcinoma: A potential four-long noncoding RNA prognostic signature.
Sui J; Yang S; Liu T; Wu W; Xu S; Yin L; Pu Y; Zhang X; Zhang Y; Shen B; Liang G
J Cell Biochem; 2019 Jan; 120(1):705-714. PubMed ID: 30125988
[TBL] [Abstract][Full Text] [Related]
58. Integrated analysis of competing endogenous RNA (ceRNA) networks in subacute stage of spinal cord injury.
Wang N; He L; Yang Y; Li S; Chen Y; Tian Z; Ji Y; Wang Y; Pang M; Wang Y; Liu B; Rong L
Gene; 2020 Feb; 726():144171. PubMed ID: 31669638
[TBL] [Abstract][Full Text] [Related]
59. Circular RNA-microRNA-mRNA network identified circ_0007618 and circ_0029426 as new valuable biomarkers for lung adenocarcinoma.
Zhang Q; Sun Y; Wang C; Shao F
Bioengineered; 2022 Mar; 13(3):6258-6271. PubMed ID: 35212617
[TBL] [Abstract][Full Text] [Related]
60. Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers.
Li R; Yang YE; Yin YH; Zhang MY; Li H; Qu YQ
J Transl Med; 2019 Sep; 17(1):324. PubMed ID: 31558162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
